The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

Info Edge, Intel, SoftBank and Tencent are all in line for exits as PolicyBazaar files for an initial public offering in India.

Mitsui and Nan Fung are among the backers celebrating Rallybio’s flotation on the Nasdaq Global Select Market following an $80.6m offering.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

The Sanofi Ventures-backed vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The transport provider is merging with publicly-listed Queen's Gambit Growth Capital at a $1.5bn valuation, with Zain and Agility both investing.

Ant Group-backed mobility serices provider has cancelled its initial public offering in the wake of regulatory crackdowns in its home country of China.

The Verizon-backed programmatic advertising software provider is joining forces with Nasdaq-listed CAP Acquisition Corporation.

IN8Bio, a University of Alabama spinout and cancer immunotherapy developer, has pulled in $40m through its IPO.

SoftBank-backed barbershop booking service Squire raised $60m at a $750m valuation while card issuing platform developer Lithic was valued at $800m in a round featuring Exor.